Skip to content
[P]pubcas
🌐 English
EnglishEnglish简体中文Simplified Chinese繁體中文Traditional ChineseEspañolSpanishFrançaisFrenchDeutschGermanPortuguêsPortugueseРусскийRussianالعربيةArabic日本語Japanese한국어KoreanItalianoItalianNederlandsDutchPolskiPolishTürkçeTurkishTiếng ViệtVietnameseไทยThaiBahasa IndonesiaIndonesianBahasa MelayuMalayहिन्दीHindiবাংলাBengaliاردوUrduفارسیPersianעבריתHebrewУкраїнськаUkrainianRomânăRomanianČeštinaCzechSlovenčinaSlovakMagyarHungarianΕλληνικάGreekБългарскиBulgarianSvenskaSwedishDanskDanishNorsk bokmålNorwegian BokmalSuomiFinnishEestiEstonianLatviešuLatvianLietuviųLithuanianSlovenščinaSlovenianHrvatskiCroatianСрпскиSerbianBosanskiBosnianМакедонскиMacedonianShqipAlbanianAzərbaycanAzerbaijaniქართულიGeorgianՀայերենArmenianҚазақшаKazakhOʻzbekchaUzbekКыргызчаKyrgyzТоҷикӣTajikTürkmençeTurkmenМонголMongolianनेपालीNepaliසිංහලSinhalaதமிழ்TamilతెలుగుTeluguमराठीMarathiગુજરાતીGujaratiಕನ್ನಡKannadaമലയാളംMalayalamਪੰਜਾਬੀPunjabiଓଡ଼ିଆOdiaঅসমীয়াAssameseမြန်မာBurmeseខ្មែរKhmerລາວLaoFilipinoFilipinoKiswahiliSwahiliAfrikaansAfrikaansአማርኛAmharicHausaHausaYorùbáYorubaIgboIgboisiZuluZuluisiXhosaXhosaSoomaaliSomaliMalagasyMalagasyKinyarwandaKinyarwandaChiShonaShonaChichewaChichewaپښتوPashtoسنڌيSindhiKurdîKurdish KurmanjiБеларускаяBelarusianÍslenskaIcelandicGaeilgeIrishCymraegWelshMaltiMalteseEuskaraBasqueCatalàCatalanGalegoGalicianLëtzebuergeschLuxembourgishBasa JawaJavaneseBasa SundaSundaneseKreyòl ayisyenHaitian CreoleMāoriMaoriGagana SamoaSamoanLatinaLatinEsperantoEsperanto
Independent chemical reference Compare
Chemical substance record

Ibufenac

1553-60-2C12H16O2192.258 g/mol

A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is replaced by a 4-isobutylphenyl group. Although it was shown to be effective in treatment of rheumatoid arthritis, the clinical use of ibufenac was discontinued due to hepatotoxic side-effects. — ChEBI

Quick answers Safety references

Quick answers about Ibufenac

Identity · formula · mass

What is Ibufenac, CAS 1553-60-2?

Ibufenac is the substance linked to CAS 1553-60-2 in ChEBI entry CHEBI:76158. The reported formula is C12H16O2. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.

Source ↗

What is the molar mass of Ibufenac?

The ChEBI-reported molar mass is 192.258 g/mol for formula C12H16O2. Its source-reported monoisotopic mass is 192.11503 Da; that uses a specific isotope composition and is a different quantity.

Source ↗

Which PubChem properties are available for Ibufenac?

CID 15250 is connected to this record by an exact InChIKey match. PubChem reports exact mass 192.115029749 Da. computed XLogP 3.1. Values and source conventions are shown separately in the property tables below.

Source ↗

Identity & molecular properties

Source-linked values
CAS number1553-60-2ChEBI ↗
Chemical formulaC12H16O2ChEBI ↗
Molar mass192.258 g/molChEBI ↗
Monoisotopic mass192.11503 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:76158ChEBI ↗

PubChem molecular properties

PubChem
Molar mass192.25 g/molPubChem ↗
Exact mass192.115029749 DaPubChem ↗
Computed XLogP3.1PubChem ↗
Topological polar surface area (Ų)37.3PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors2PubChem ↗
Rotatable bonds4PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
ibufenac
(4-isobutylphenyl)acetic acid
CYWFCPPBTWOZSF-UHFFFAOYSA-N
CC(C)Cc1ccc(CC(=O)O)cc1
InChI=1S/C12H16O2/c1-9(2)7-10-3-5-11(6-4-10)8-12(13)14/h3-6,9H,7-8H2,1-2H3,(H,13,14)

Names & synonyms

(4-isobutylphenyl)acetic acid[4-(2-methylpropyl)phenyl]acetic acidDytransinibufenacoibufenacum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

non-steroidal anti-inflammatory drugnon-narcotic analgesicEC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitorhepatotoxic agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00520134 mol

Uses 192.258 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 12 atoms
74.97%
O
Oxygen · 2 atoms
16.64%
H
Hydrogen · 16 atoms
8.39%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye. ↗Journal of pharmacokinetics and biopharmaceutics · 1992 Aug · PMID 1479559
US2008014272 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US2011212904 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US4391814 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:76158

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 15250 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.